Nonspanning Bivalent Ligands as Improved Surface Receptor Binding Inhibitors of the Cholera Toxin B Pentamer

Mammen, 1998, Polyvalent interactions in biological systems, Angew. Chem. (Int. Edit.), 37, 2755 Kiessling, 2000, Principles for multivalent ligand design, Annu. Rep. Med. Chem, 35, 321, 10.1016/S0065-7743(00)35030-8 Hubble, 1999, A model of multivalent ligand-receptor equilibria which explains the effect of multivalent binding inhibitors, Mol. Immunol, 36, 13, 10.1016/S0161-5890(98)00116-3 Gargano, 2001, Multivalent inhibition of AB(5) toxins, J. Am. Chem. Soc, 123, 12909, 10.1021/ja016305a Kitov, 2003, On the nature of the multivalency effect, J. Am. Chem. Soc, 125, 16271, 10.1021/ja038223n Burke, 2000, Synergistic formation of soluble lectin clusters by a templated multivalent saccharide ligand, J. Am. Chem. Soc, 122, 4518, 10.1021/ja000068e Dimick, 1999, On the meaning of affinity, J. Am. Chem. Soc, 121, 10286, 10.1021/ja991729e Wright, 2001, Multivalent binding in the design of bioactive compounds, Curr. Org. Chem, 5, 1107, 10.2174/1385272013374806 Pang, 2003, Rational design of alkylene-linked bis-pyridiniumalidoximes as improved acetylcholinesterase reactivators, Chem. Biol, 10, 491, 10.1016/S1074-5521(03)00126-1 Wong, 2003, Acetylcholinesterase complexed with bivalent ligands related to huperzine A, J. Am. Chem. Soc, 125, 363, 10.1021/ja021111w Han, 1999, Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based aChE inhibitors, Bioorg. Med. Chem, 7, 2569, 10.1016/S0968-0896(99)00178-9 Tamiz, 2001, Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors, J. Med. Chem, 44, 1615, 10.1021/jm000552s Abadi, 2002, Dopamine/serotonin receptor ligands, part III, Arch. Pharm, 335, 367, 10.1002/1521-4184(200211)335:8<367::AID-ARDP367>3.0.CO;2-C Glick, 1991, Ligand recognition by influenza virus, J. Biol. Chem, 266, 23660, 10.1016/S0021-9258(18)54335-0 Kitov, 2003, Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a shiga-like toxin, J. Am. Chem. Soc, 125, 3284, 10.1021/ja0258529 Lundquist, 2000, Multivalency effects in protein-carbohydrate interaction, J. Org. Chem, 65, 8245, 10.1021/jo000943e Fan, 2000, AB(5) toxins, Curr. Opin. Struct. Biol, 10, 680, 10.1016/S0959-440X(00)00152-4 Spangler, 1992, Structure and function of cholera toxin and the related escherichia coli heat-labile enterotoxin, Microbiol. Rev, 56, 622, 10.1128/MMBR.56.4.622-647.1992 Dewolf, 1994, Interaction of a cholera-toxin derivative containing a reduced number of receptor-binding sites with intact-cells in culture, Biochimica Et Biophysica Acta-Molecular Cell Research, 1223, 296, 10.1016/0167-4889(94)90240-2 Fan, 2000, High affinity pentavalent ligands of escherichia coli heat-labile enterotoxin by modular structure-based design, J. Am. Chem. Soc, 122, 2663, 10.1021/ja993388a Merritt, 2002, Characterization and crystal structure of a high-affinity pentavalent receptor-binding inhibitor for cholera toxin and E. coli heat-labile enterotoxin, J. Am. Chem. Soc, 124, 8818, 10.1021/ja0202560 Zhang, 2002, Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin, J. Am. Chem. Soc, 124, 12991, 10.1021/ja027584k Minke, 1999, Structure-based exploration of the ganglioside GM1 binding sites of escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists, Biochemistry, 38, 5684, 10.1021/bi982649a Pickens, 2002, Anchor-based design of improved receptor-binding antagonists of cholera toxin and escherichia coli heat-labile enterotoxin that display multiple binding modes, Chem. Biol, 9, 215, 10.1016/S1074-5521(02)00097-2 Mitchell, 2004, 3,5-substituted phenylgalactosides as leads in designing effective cholera toxin antagonists, Bioorg. Med. Chem, 12, 907, 10.1016/j.bmc.2003.12.019 Knoll, 1983, Polymer-protein interactions-comparison of experiment and excluded volume theory, J. Biol. Chem, 258, 5710, 10.1016/S0021-9258(20)81951-6 Merritt, 1997, Structural foundation for the design of receptor antagonists targeting escherichia coli heat-labile enterotoxin, Structure, 5, 1485, 10.1016/S0969-2126(97)00298-0 Merritt, 1995, AB(5) toxins, Curr. Opin. Struct. Biol, 5, 165, 10.1016/0959-440X(95)80071-9 Mammen, 1995, Effective inhibitors of hemagglutination by influenza-virus synthesized from polymers having active ester groups-insight into mechanism of inhibition, J. Med. Chem, 38, 4179, 10.1021/jm00021a007 Sigal, 1996, Polyacrylamides bearing pendant α-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus, J. Am. Chem. Soc, 118, 3789, 10.1021/ja953729u Choi, 1997, Generation and in situ evaluation of libraries of poly(acrylic acid) presenting sialosides as side chains as polyvalent inhibitors of influenza-mediated hemagglutination, J. Am. Chem. Soc, 119, 4103, 10.1021/ja963519x Merritt, 1998, The 1.25 angstrom resolution refinement of the cholera toxin B-pentamer, J. Mol. Biol, 282, 1043, 10.1006/jmbi.1998.2076 Otwinowski, 1997, Processing of x-ray diffraction data collected in oscillation mode, Macromolecular crystallography, 276, 307, 10.1016/S0076-6879(97)76066-X Vagin, 1997, Molrep, J. Appl. Crystallogr, 30, 1022, 10.1107/S0021889897006766 Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr. Sect. D-Biol. Crystallogr, 53, 240, 10.1107/S0907444996012255 Perrakis, 1999, Automated protein model building combined with iterative structure refinement, Nat. Struct. Biol, 6, 458, 10.1038/8263 McRee, 1999, Xtalview xfit-a versatile program for manipulating atomic coordinates and electron density, J. Struct. Biol, 125, 156, 10.1006/jsbi.1999.4094 Vaguine, 1999, Sfcheck, Acta Crystallogr. Sect. D-Biol. Crystallogr, 55, 191, 10.1107/S0907444998006684 Hooft, 1996, Errors in protein structures, Nature, 381, 272, 10.1038/381272a0 Merritt, 1997, Raster3d, Method. Enzymol, 277, 505, 10.1016/S0076-6879(97)77028-9